Accendra Health (ACH) Insider Trades, Congress & Funds

Smart money at a glance

Filings to Oct 30, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersSEC Form 4, last 90 days: $0No open-market trades
CongressSTOCK Act, last 180 days: NoneNo trades disclosed
Big fundsSEC 13F, latest quarter: NoneNo large changes
Federal contractsUSAspending.gov, last 12 months: No awardsNone on record

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Questions about ACH filings

Are insiders buying or selling Accendra Health Inc (ACH) stock?

Neither. Accendra Health Inc (ACH) insiders filed no open-market purchases or sales in the 90 days to Oct 30, 2026, according to SEC Form 4 filings.

Which members of Congress have traded ACH recently?

None. No member of Congress disclosed a ACH trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this ACH smart-money data?

This summary uses filings available on Oct 30, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

No recent filings found.

17 funds hold a position.

Questions about ACH filings

Are insiders buying or selling Accendra Health Inc (ACH) stock?

Neither. Accendra Health Inc (ACH) insiders filed no open-market purchases or sales in the 90 days to Oct 30, 2026, according to SEC Form 4 filings.

Which members of Congress have traded ACH recently?

None. No member of Congress disclosed a ACH trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this ACH smart-money data?

Checking federal contract awards

Unlock everything for $29/month

Unlock for $29/month

Reported Aug 10, 2026

Earnings came in 46.2% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Aug 10, 2026

Period ending

Jun 30, 2026

Earnings per share

-$0.19-46.15% miss

-$0.13 expected

Revenue

$613.2M

SEC filing

Next report

Estimated report: Nov 5, 2026, in 6 days

Previous reports

Period ending	Reported	EPS / estimate	EPS surprise	Revenue / income	Surprise
Jun 30, 2026	Aug 10, 2026	-$0.19 / -$0.13Alpha Vantage	-46.15% miss	$613.2M No estimateSEC filing	Unavailable
Mar 31, 2026	May 11, 2026	-$0.04 / -$0.10Alpha Vantage	+60.00% beat	$627.8M No estimateSEC filing	Unavailable
Dec 31, 2025	Feb 19, 2026	$0.21 / $0.22Alpha Vantage	-4.55% miss	$2.76B No estimateYear ended Dec 31, 2025 · SEC filing	Unavailable
Sep 30, 2025	Oct 30, 2025	$0.25 / $0.23Alpha Vantage	+8.70% beat	$697.3M No estimateSEC filing	Unavailable
Jun 30, 2025	Aug 11, 2025	$0.26 / $0.28Alpha Vantage	-7.14% miss	$681.9M No estimateSEC filing	Unavailable
Mar 31, 2025	May 8, 2025	$0.23 / $0.20Alpha Vantage	+15.00% beat	$673.9M No estimateSEC filing	Unavailable
Dec 31, 2024	Feb 28, 2025	Unavailable	-	$2.68B No estimateYear ended Dec 31, 2024 · SEC filing	Unavailable
Sep 30, 2024	Nov 4, 2024	$0.42 / $0.41Alpha Vantage	+2.44% beat	$686.8M No estimateSEC filing	Unavailable

EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.

Open: $0.23
52-wk high: $5.12
High: $0.24
52-wk low: $0.19
Low: $0.22
Prev close: $0.23
Mkt cap: $17.9M
ROE: -198.4%
Fwd P/E: 6.9x
Beta: 1.57
P/S: 0.0x
P/B: 1.1x
Profit margin: -11.4%
Op margin: -1.5%

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -11.4%
Forward P/E: 6.94
Market cap: $18M

Valuation

P/S0.01
P/B1.07

Quality

Operating margin-1.5%
ROE-198.4%
ROA0.6%

Growth

Beta1.57

Technicals

Price structure

This stock is under pressure, and looks oversold after a sharp drop.

Trend

Under pressure

0 / 100

RSI 14

21oversold

20D volatility

148%annualized

52-week range

$0.23

$0.19$5.12

20D support

$0.19recent floor

20D resistance

$0.57recent ceiling

Returns

5D +10.5%20D -58.2%60D -92.1%

Price vs moving averages

SMA20 -25.7%SMA50 -68.1%SMA200 -89.6%

Volume pace

1.64xvs prior 20D

Smart money at a glance

Filings to Oct 30, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersSEC Form 4, last 90 days: $0No open-market trades
CongressSTOCK Act, last 180 days: NoneNo trades disclosed
Big fundsSEC 13F, latest quarter: NoneNo large changes
Federal contractsUSAspending.gov, last 12 months: No awardsNone on record

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Questions about ACH filings

Are insiders buying or selling Accendra Health Inc (ACH) stock?

Neither. Accendra Health Inc (ACH) insiders filed no open-market purchases or sales in the 90 days to Oct 30, 2026, according to SEC Form 4 filings.

Which members of Congress have traded ACH recently?

None. No member of Congress disclosed a ACH trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this ACH smart-money data?

No recent filings found.

17 funds hold a position.

Questions about ACH filings

Are insiders buying or selling Accendra Health Inc (ACH) stock?

Neither. Accendra Health Inc (ACH) insiders filed no open-market purchases or sales in the 90 days to Oct 30, 2026, according to SEC Form 4 filings.

Which members of Congress have traded ACH recently?

None. No member of Congress disclosed a ACH trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this ACH smart-money data?

Checking federal contract awards

Unlock everything for $29/month

Unlock for $29/month

Reported Aug 10, 2026

Earnings came in 46.2% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Aug 10, 2026

Period ending

Jun 30, 2026

Earnings per share

-$0.19-46.15% miss

-$0.13 expected

Revenue

$613.2M

SEC filing

Next report

Estimated report: Nov 5, 2026, in 6 days

Previous reports

Period ending	Reported	EPS / estimate	EPS surprise	Revenue / income	Surprise
Jun 30, 2026	Aug 10, 2026	-$0.19 / -$0.13Alpha Vantage	-46.15% miss	$613.2M No estimateSEC filing	Unavailable
Mar 31, 2026	May 11, 2026	-$0.04 / -$0.10Alpha Vantage	+60.00% beat	$627.8M No estimateSEC filing	Unavailable
Dec 31, 2025	Feb 19, 2026	$0.21 / $0.22Alpha Vantage	-4.55% miss	$2.76B No estimateYear ended Dec 31, 2025 · SEC filing	Unavailable
Sep 30, 2025	Oct 30, 2025	$0.25 / $0.23Alpha Vantage	+8.70% beat	$697.3M No estimateSEC filing	Unavailable
Jun 30, 2025	Aug 11, 2025	$0.26 / $0.28Alpha Vantage	-7.14% miss	$681.9M No estimateSEC filing	Unavailable
Mar 31, 2025	May 8, 2025	$0.23 / $0.20Alpha Vantage	+15.00% beat	$673.9M No estimateSEC filing	Unavailable
Dec 31, 2024	Feb 28, 2025	Unavailable	-	$2.68B No estimateYear ended Dec 31, 2024 · SEC filing	Unavailable
Sep 30, 2024	Nov 4, 2024	$0.42 / $0.41Alpha Vantage	+2.44% beat	$686.8M No estimateSEC filing	Unavailable

Open: $0.23
52-wk high: $5.12
High: $0.24
52-wk low: $0.19
Low: $0.22
Prev close: $0.23
Mkt cap: $17.9M
ROE: -198.4%
Fwd P/E: 6.9x
Beta: 1.57
P/S: 0.0x
P/B: 1.1x
Profit margin: -11.4%
Op margin: -1.5%

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -11.4%
Forward P/E: 6.94
Market cap: $18M

Valuation

P/S0.01
P/B1.07

Quality

Operating margin-1.5%
ROE-198.4%
ROA0.6%

Growth

Beta1.57

Technicals

Price structure

This stock is under pressure, and looks oversold after a sharp drop.

Trend

Under pressure

0 / 100

RSI 14

21oversold

20D volatility

148%annualized

52-week range

$0.23

$0.19$5.12

20D support

$0.19recent floor

20D resistance

$0.57recent ceiling

Returns

5D +10.5%20D -58.2%60D -92.1%

Price vs moving averages

SMA20 -25.7%SMA50 -68.1%SMA200 -89.6%

Volume pace

1.64xvs prior 20D

Accendra Health Inc

Smart money at a glance

What do analysts expect?

Questions about ACH filings

Questions about ACH filings

How top traders are positioned

Unlock everything for $29/month

Earnings came in 46.2% below what analysts expected.

Estimated report: Nov 5, 2026, in 6 days

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Accendra Health Inc

Smart money at a glance

What do analysts expect?

Questions about ACH filings

Questions about ACH filings

How top traders are positioned

Unlock everything for $29/month

Earnings came in 46.2% below what analysts expected.

Estimated report: Nov 5, 2026, in 6 days

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Accendra Health Inc

Overview

Questions about ACH filings

Smart money

Unlock everything for $29/month

Earnings

Financials

Technicals

Ask it in Claude or ChatGPT.

Accendra Health Inc

Overview

Questions about ACH filings

Smart money

Unlock everything for $29/month

Earnings

Financials

Technicals

Ask it in Claude or ChatGPT.